Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5634352 | World Neurosurgery | 2017 | 29 Pages |
Abstract
In the Surveillance, Epidemiology, and End Results (SEER) program database, GTR-associated survival benefit in A2 patients â¥50 years old resembled that observed in glioblastoma, while GTR in A2 patients <50 years old was associated with a distinctly more favorable survival profile.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Alexander J. Schupper, Brian R. Hirshman, Kate T. Carroll, Mir Amaan Ali, Bob S. Carter, Clark C. Chen,